Implications of depressed antithrombin-3 activity associated with oral contraceptives.
D000991:Antithrombins / Q000032:analysis*; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced; D008722:Methods; D008881:Migraine Disorders / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D013917:Thrombin; D013924:Thrombophlebitis / Q000139:chemically induced; D013997:Time Factors
D000991:Antithrombins; D003276:Contraceptives, Oral; D013917:Thrombin